MY148277A - Treatment of cartilage disorders with fgf-18 - Google Patents

Treatment of cartilage disorders with fgf-18

Info

Publication number
MY148277A
MY148277A MYPI20090702A MYPI20090702A MY148277A MY 148277 A MY148277 A MY 148277A MY PI20090702 A MYPI20090702 A MY PI20090702A MY PI20090702 A MYPI20090702 A MY PI20090702A MY 148277 A MY148277 A MY 148277A
Authority
MY
Malaysia
Prior art keywords
treatment
fgf
osteoarthritis
cartilage disorders
cartilage disorder
Prior art date
Application number
MYPI20090702A
Other languages
English (en)
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of MY148277A publication Critical patent/MY148277A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI20090702A 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18 MY148277A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28

Publications (1)

Publication Number Publication Date
MY148277A true MY148277A (en) 2013-03-29

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20090702A MY148277A (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Country Status (11)

Country Link
CN (1) CN101505787B (pt)
BR (1) BRPI0715728A8 (pt)
DK (1) DK2054050T3 (pt)
ES (1) ES2392883T3 (pt)
MY (1) MY148277A (pt)
NZ (1) NZ574216A (pt)
PT (1) PT2054050E (pt)
RS (1) RS52710B (pt)
SI (1) SI2054050T1 (pt)
UA (1) UA99818C2 (pt)
ZA (1) ZA200900426B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104736723B (zh) * 2012-08-06 2017-10-31 默克专利有限公司 用于预测对fgf‑18化合物的响应性的遗传标记
JP6510547B2 (ja) * 2014-02-20 2019-05-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Ｆｇｆ−１８を含むインプラント
HUE040350T2 (hu) * 2014-02-20 2019-03-28 Merck Patent Gmbh FGF-18 vegyületadagoló étrend
MX2016010873A (es) * 2014-02-20 2016-11-17 Merck Patent Gmbh Factor de crecimiento de fibroblastos 18 en los procedimientos para el trasplante de injertos y para ingenieria de tejidos.
CN107405388A (zh) * 2015-01-08 2017-11-28 衣阿华大学研究基金会 用于体内关节软骨再生的方法
WO2017008758A1 (en) 2015-07-15 2017-01-19 Prosit Sole Biotechnology (Beijing) Co., Ltd Fusion polypeptides and methods of use
JP7140677B2 (ja) * 2015-08-13 2022-09-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｆｇｆ－１８化合物を含む組み合わせ組成物
AU2020388637A1 (en) * 2019-11-21 2022-07-07 Remedium Bio, Inc. Growth factor restoration
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2493840T3 (es) * 2002-10-07 2014-09-12 Zymogenetics, Inc. Procedimiento de administración de FGF-18
ES2706848T3 (es) * 2004-07-06 2019-04-01 Zymogenetics Inc Composición farmacéutica que comprende FGF18 y antagonista de IL-1 y método de uso
AU2005314438B2 (en) * 2004-12-10 2012-03-29 Zymogenetics, Inc. FGF18 production in prokaryotic hosts

Also Published As

Publication number Publication date
CN101505787A (zh) 2009-08-12
CN101505787B (zh) 2013-09-04
SI2054050T1 (sl) 2012-12-31
RS52710B (sr) 2013-08-30
BRPI0715728A2 (pt) 2013-09-17
BRPI0715728A8 (pt) 2018-04-03
NZ574216A (en) 2011-11-25
ES2392883T3 (es) 2012-12-14
ZA200900426B (en) 2010-04-28
UA99818C2 (ru) 2012-10-10
DK2054050T3 (da) 2012-09-03
PT2054050E (pt) 2012-09-17

Similar Documents

Publication Publication Date Title
WO2008023063A3 (en) Treatment of cartilage disorders with fgf-18
MY148277A (en) Treatment of cartilage disorders with fgf-18
TW200716672A (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
WO2007134326A3 (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule
IL201479A (en) Use of tapentadol for the preparation of pain medication
MY162067A (en) Combination therapy for treatment of patients with neurological disorders and cerebral infarction
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
PH12012501740A1 (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
MXPA05007462A (es) Derivados de pirrolopiridazina.
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
NZ597419A (en) Formulations for the treatment of deep tissue pain
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
EA201001749A1 (ru) Способ лечения недифференцированного артрита
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
TW200734334A (en) Treatment of substance abuse
PT1670489E (pt) Utilização de xénon com hipotermia para o tratamento de asfixia neonatal
EA201070193A1 (ru) Лечение детских опухолей
IL198202A0 (en) Peptide-cytotoxic conjugates
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
EP2124554A4 (en) COMPOSITIONS AND METHODS FOR CANCER TREATMENT
MX2008013477A (es) Compuestos biciclicos de tetrahidropirrol.